MBIA (MBI) to Sell MBIA UK to Assured Guaranty (AGO)
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
MBIA Insurance Corporation (NYSE: MBI) today announced that its wholly owned subsidiary, MBIA UK (Holdings) Limited (MBIA UK Holdings), has entered into an agreement to sell MBIA UK Insurance Limited (MBIA UK) to Assured Guaranty Corp. (Assured), a subsidiary of Assured Guaranty Ltd. (NYSE: AGO). The purchase price consists of the transfer to MBIA UK Holdings of notes issued by Zohar II 2005-1 CLO (Zohar II Notes) with an aggregate outstanding principal amount of approximately $347 million (Assured Zohar II Notes) and a cash payment by MBIA UK Holdings to Assured of $23 million. The transaction is subject to certain closing conditions including the receipt of regulatory approvals from the Prudential Regulation Authority of the United Kingdom, the New York State Department of Financial Services (NYSDFS) and the Maryland Insurance Administration. The sale of MBIA UK, effectively in exchange for the Assured Zohar II Notes, is part of MBIA Corp.’s strategy to address the maturity of the Zohar II Notes on January 20, 2017, which had approximately $772 million of gross par outstanding as of June 30, 2016. MBIA Corp. does not currently expect that the Zohar II CLO will have sufficient cash flow to repay all of the Zohar II Notes at maturity. There is no assurance that the transaction will be completed or that MBIA Corp.’s strategies will be successful. The transaction is scheduled to close in early January of 2017.
Anthony McKiernan, Chief Financial Officer and President of MBIA Insurance Corp., noted, “As we have previously stated, the sale of MBIA UK is one of the elements of our plan to enable MBIA Corp. to address its insurance obligations regarding the Zohar II Notes. The acquisition of the Assured Zohar II Notes reduces MBIA Corp.’s liability under its Zohar II policy and may facilitate our ability to address the remaining Zohar II Notes on or before their maturity.” He added, “While the sale of MBIA UK, if completed, will be an important and meaningful accomplishment, MBIA Corp. still has substantially more to do.”
MBIA Corp. is in the process of exploring a variety of additional strategies to address its obligations with respect to the Zohar II Notes. These strategies may involve the restructuring or repurchase of certain Zohar II Notes that may require substantial third party financing, which MBIA Corp. is seeking to arrange. Its ability to do so, however, is constrained and there is no assurance that it will be able to secure a financing on acceptable terms. If, notwithstanding the transaction announced today, MBIA Corp. is unable to successfully implement its strategies for restructuring or otherwise satisfying its obligations under the Zohar II Notes, it does not expect to have a sufficient amount of liquid assets to pay all claims in respect to the Zohar II Notes at maturity (irrespective of whether the sale of MBIA UK is completed). MBIA Corp. anticipates that the approval by the NYSDFS of the sale of MBIA UK, if granted, would be based on (among other things) the NYSDFS concluding that MBIA Corp. will successfully execute its strategies to meet and/or restructure its obligations on the Zohar II Notes in a manner acceptable to the NYSDFS.
MBIA Corp. believes that if the NYSDFS concludes at any time that MBIA Corp. will not be able to restructure or otherwise satisfy its obligations under the Zohar II Notes on terms satisfactory to the NYSDFS, while maintaining sufficient assets to readily pay other policyholder claims, the NYSDFS would likely put MBIA Corp. into a rehabilitation or liquidation proceeding under Article 74 of the New York Insurance Law and/or take such other actions as the NYSDFS may deem necessary to protect the interests of MBIA Corp.’s policyholders. The determination to commence such a proceeding or take other such actions is within the exclusive control of the NYSDFS. The NYSDFS enjoys broad discretion in this regard, and any determination they may make would not be limited to consideration of the matters described above. No assurance is given as to what action, if any, the NYSDFS may take.
Barclays Capital is acting as financial advisor, and Debevoise & Plimpton LLP is acting as legal advisor, on the sale of MBIA UK.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rite Aid (RAD)/Walgreens (WBA) Antitrust Concerns Doesn't Mean Deal is Dead, Says Deutsche Bank
- Tucows (TCX) to Acquire eNom from Rightside (NAME) for $83.5M
- FTC not sold on Walgreens' plan to win nod for Rite Aid deal: Bloomberg
Create E-mail Alert Related CategoriesCorporate News, Mergers and Acquisitions
Related EntitiesBarclays, Earnings, Definitive Agreement
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!